secwatch.observer — SEC 8-K summary
======================================

Issuer:     LifeStance Health Group, Inc. (LFST)
CIK:        0001845257
Form:       8-K
Filed at:   2025-02-27T23:59:59+00:00
Accession:  0000950170-25-028099
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LifeStance Q4 revenue $325.5M (+16% YoY); 2025 EBITDA guidance $130-150M
------------------------------------------------------------------------

- Q4 revenue $325.5M (+16% YoY); full year $1.251B (+19% YoY).
- Net loss narrowed to $7.1M in Q4 vs $45.0M prior; full year $57.4M vs $186.3M.
- Adjusted EBITDA Q4 $32.8M (+62% YoY); full year $119.7M (+103% YoY).
- 2025 guidance: revenue $1.40B-$1.44B, Center Margin $440M-$464M, Adj. EBITDA $130M-$150M.
- Free cash flow $85.7M for 2024; cash $154.6M, net long-term debt $279.8M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845257/000095017025028099/0000950170-25-028099-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845257/000095017025028099/lfst-20250227.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-028099

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer